FDA Approved: BORTEZOMIB — Original Application (Hospira, Inc.)

View source ↗

Summary

FDA approved Hospira's generic version of bortezomib for injection under ANDA208460, enabling a generic option for the same indications as the branded product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mantle Cell Lymphoma
• Multiple Myeloma

Drugs mentioned

• Bortezomib (bortezomib)

Snippet

ORIG AP for BORTEZOMIB (BORTEZOMIB)